Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1977 3
1981 1
1983 4
1984 2
1985 5
1986 4
1987 8
1988 6
1989 9
1990 3
1991 5
1992 3
1993 6
1994 6
1995 5
1996 7
1997 6
1998 10
1999 9
2000 11
2001 11
2002 13
2003 18
2004 20
2005 17
2006 15
2007 19
2008 26
2009 34
2010 21
2011 47
2012 46
2013 49
2014 61
2015 53
2016 49
2017 60
2018 53
2019 40
2020 59
2021 42
2022 52
2023 40
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

871 results

Results by year

Filters applied: . Clear all
Page 1
Targeting mutations in cancer.
Waarts MR, Stonestrom AJ, Park YC, Levine RL. Waarts MR, et al. Among authors: park yc. J Clin Invest. 2022 Apr 15;132(8):e154943. doi: 10.1172/JCI154943. J Clin Invest. 2022. PMID: 35426374 Free PMC article. Review.
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M, Ye D, Feyerabend S, Protheroe A, De Porre P, Kheoh T, Park YC, Todd MB, Chi KN; LATITUDE Investigators. Fizazi K, et al. Among authors: park yc. N Engl J Med. 2017 Jul 27;377(4):352-360. doi: 10.1056/NEJMoa1704174. Epub 2017 Jun 4. N Engl J Med. 2017. PMID: 28578607 Free article. Clinical Trial.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. Among authors: park yc. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Demetri GD, von Mehren M, Jones RL, Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H, Van Tine BA, Spira A, Dean A, Khokhar NZ, Park YC, Knoblauch RE, Parekh TV, Maki RG, Patel SR. Demetri GD, et al. Among authors: park yc. J Clin Oncol. 2016 Mar 10;34(8):786-93. doi: 10.1200/JCO.2015.62.4734. Epub 2015 Sep 14. J Clin Oncol. 2016. PMID: 26371143 Free PMC article. Clinical Trial.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. Among authors: park yc. Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601341 Clinical Trial.
Genome-wide meta-analysis of 92 cardiometabolic protein serum levels.
Gilly A, Park YC, Tsafantakis E, Karaleftheri M, Dedoussis G, Zeggini E. Gilly A, et al. Among authors: park yc. Mol Metab. 2023 Dec;78:101810. doi: 10.1016/j.molmet.2023.101810. Epub 2023 Sep 29. Mol Metab. 2023. PMID: 37778719 Free PMC article.
Yeast metabolic engineering for carbon dioxide fixation and its application.
Rin Kim S, Kim SJ, Kim SK, Seo SO, Park S, Shin J, Kim JS, Park BR, Jin YS, Chang PS, Park YC. Rin Kim S, et al. Among authors: park yc. Bioresour Technol. 2022 Feb;346:126349. doi: 10.1016/j.biortech.2021.126349. Epub 2021 Nov 17. Bioresour Technol. 2022. PMID: 34800639 Review.
Recent advances in biological production of sugar alcohols.
Park YC, Oh EJ, Jo JH, Jin YS, Seo JH. Park YC, et al. Curr Opin Biotechnol. 2016 Feb;37:105-113. doi: 10.1016/j.copbio.2015.11.006. Epub 2015 Dec 23. Curr Opin Biotechnol. 2016. PMID: 26723007 Review.
871 results